Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 37, 2008, Pages 14017-14022

  Schmidt, Nathan W ^a   Podyminogin, Rebecca L ^a   Butler, Noah S ^a   Badovinac, Vladimir P ^a   Tucker, Brad J ^b   Bahjat, Keith S ^c,e   Lauer, Peter ^c   Reyes Sandoval, Arturo ^d   Hutchings, Claire L ^d   Moore, Anne C ^d   Gilbert, Sarah C ^d   Hill, Adrian V ^d   Bartholomay, Lyric C ^b   Harty, John T ^a  

^a UNIVERSITY OF IOWA   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c Anza Therapeutics Inc   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Medarex Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL LINE; DISEASE MODEL; EXPERIMENTAL MOUSE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SPOROZOITE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; IMMUNOLOGIC MEMORY; MALARIA; MICE; MICE, INBRED BALB C; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; SUBSTRATE SPECIFICITY; TIME FACTORS;

MUS; PLASMODIUM BERGHEI; PLASMODIUM YOELII;

EID: 52949138683     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805452105     Document Type: Article

References (36)

1. Greenwood B, Mutabingwa T (2002) Malaria in 2002. Nature 415:670-672.
2. Nussenzweig RS, Vanderberg J, Most H, Orton C (1967) Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216:160-162.
3. Jobe O, et al. (2007) Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis 196:599-607.
4. Tarun AS, et al. (2007) Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 196:608-616.
5. Li S, et al. (1993) Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T cell-mediated protective immunity against malaria. Proc Natl Acad Sci USA 90:5214-5218.
6. Schneider J, et al. (1998) Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4:397-402.
7. Sedegah M, et al. (2002) Persistence of protective immunity to malaria induced byDNA priming and poxvirus boosting: Characterization of effector and memory CD8(+)-T cell populations. Infect Immun 70:3493-3499.
8. Anderson RJ, et al. (2004) Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J Immunol 172:3094-3100.
9. Tao D, et al. (2005) Yellow fever 17D as a vaccine vector for microbial CTL epitopes: Protection in a rodent malaria model. J Exp Med 201:201-209.
10. Tsuji M, Zavala F (2001) Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites. Mol Immunol 38:433-442.
11. Tsuji M, Zavala F (2003) T cells as mediators of protective immunity against liver stages of Plasmodium. Trends Parasitol 19:88-93.
12. Ophorst OJ, et al. (2006) Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect Immun 74:313-320.
13. Douradinha B, et al. (2007) Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol 37:1511-1519.
14. Nussenzweig R, Vanderberg J, Most H (1969) Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity. Mil Med 134:1176-1182.
15. Pacheco ND, McConnell E, Beaudoin RL (1979) Duration of immunity following a single vaccination with irradiated sporozoites of Plasmodium berghei. Bull World Health Organ 57 (Suppl 1):159-163.
16. Winger LA, Sinden RE (1992) Immunoprotection in mice susceptible to waning memory against the pre-erythrocytic stages of malaria after validated immunisation with irradiated sporozoites of Plasmodium berghei. Parasitol Res 78:427-432.
17. Clyde DF (1990) Immunity to falciparum and vivax malaria induced by irradiated sporozoites: A review of the University of Maryland studies, 1971-75. Bull World Health Organ 68 (Suppl):9 -12.
18. Rieckmann KH (1990) Human immunization with attenuated sporozoites. Bull World Health Organ 68 (Suppl):13-16.
19. Hoffman SL, et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185:1155-1164.
20. Webster DP, et al. (2005) Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci USA 102:4836-4841.
21. Jin Y, Kebaier C, Vanderberg J (2007) Direct microscopic quantification of dynamics of Plasmodium berghei sporozoite transmission from mosquitoes to mice. Infect Immun 75:5532-5539.
22. Sturm A, et al. (2006) Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313:1287-1290.
23. Todryk SM, Hill AV (2007) Malaria vaccines: The stage we are at. Nat Rev Microbiol 5:487-489.
24. Seder RA, Darrah PA, Roederer M (2008) T cell quality in memory and protection: Implications for vaccine design. Nat Rev Immunol 8:247-258.
25. Pope C, et al. (2001) Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol 166:3402-3409.
26. Badovinac VP, Porter BB, Harty JT (2002) Programmed contraction of CD8(+) T cells after infection. Nat Immunol 3:619-626.
27. Badovinac VP, Messingham KA, Jabbari A, Haring JS, Harty JT (2005) Accelerated CD8+ T cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 11:748-756.
28. Brockstedt DG, et al. (2004) Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci USA 101:13832-13837.
29. Hill AV (2006) Pre-erythrocytic malaria vaccines: Towards greater efficacy. Nat Rev Immunol 6:21-32.
30. Badovinac VP, Messingham KA, Hamilton SE, Harty JT (2003) Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host. J Immunol 170:4933-4942.
31. Gilbert SC, et al. (2002) Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine 20:1039-1045.
32. Gonzalez-Aseguinolaza G, et al. (2003) Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T cell epitope derived from the circumsporozoite protein of Plasmodium yoelii. J Virol 77:11859-11866.
33. Bejon P, et al. (2006) Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in amalaria endemic area. Eur J Immunol 36:2264-2272.
34. Imoukhuede EB, et al. (2006) Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men. Vaccine 24:6526-6533.
35. Bejon P, et al. (2006) Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals. Infect Immun 74(11):6331-6338.
36. Sun P, et al. (2003) Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. J Immunol 171:6961-6967.